5,614
Views
17
CrossRef citations to date
0
Altmetric
Review

Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology

ORCID Icon & ORCID Icon
Pages 1659-1667 | Received 15 Sep 2019, Accepted 05 Dec 2019, Published online: 04 Feb 2020

References

  • Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am. 2004;18:141–55. doi:10.1016/S0891-5520(03)00095-3.
  • Potter CW. A history of influenza. J Appl Microbiol. 2001;91:572–79. doi:10.1046/j.1365-2672.2001.01492.x.
  • Nickol ME, Kindrachuk J. A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918–1919. BMC Infect Dis. 2019;19. doi:10.1186/s12879-019-3750-8.
  • Lycett SJ, Duchatel F, Digard P. A brief history of bird flu. Philos Trans R Soc Lond B Biol Sci. 2019;374:20180257. doi:10.1098/rstb.2018.0257.
  • United Nations Population Division | Department of Economic and Social Affairs. [accessed 2019 November 20]. https://www.un.org/en/development/desa/population/index.asp.
  • ESCAP Statistical Online Database. [accessed 2019 November 20]. http://www.data.unescap.org/escap_stat/#dataStories.
  • Kamigaki T, Chaw L, Tan AG, Tamaki R, Alday PP, Javier JB, Olveda RM, Oshitani H, Tallo VL, et al. Seasonality of influenza and respiratory syncytial viruses and the effect of climate factors in subtropical–tropical Asia using influenza-like illness surveillance data, 2010 –2012. PLoS One. 2016;11:e0167712. doi:10.1371/journal.pone.0167712.
  • Young B, Sadarangani S, Jiang L, Wilder-Smith A, Chen MI-C. Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies. J Infect Dis. 2018;217:731–41. doi:10.1093/infdis/jix632.
  • WHO | FluNet. WHO. [accessed 2019 November 20]. http://www.who.int/influenza/gisrs_laboratory/flunet/en/.
  • Hirve S, Newman LP, Paget J, Azziz-Baumgartner E, Fitzner J, Bhat N, Vandemaele K, Zhang W. Influenza seasonality in the tropics and subtropics - when to vaccinate? PLoS One. 2016;11:e0153003. doi:10.1371/journal.pone.0153003.
  • Newman LP, Bhat N, Fleming JA, Neuzil KM. Global influenza seasonality to inform country-level vaccine programs: an analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLoS One. 2018;13:e0193263.
  • Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A, Bimohuen A, Brammer L, Bresee J, Bruno A, et al. Temporal patterns of influenza A and B in tropical and temperate countries: what are the lessons for influenza vaccination?. PLoS One. 2016 Mar 31;11(3):e0152310.
  • Kottek M, Grieser J, Beck C, Rudolf B, Rubel F. World map of the köppen-geiger climate classification updated. Meteorol Z. 2006;15:259–63. doi:10.1127/0941-2948/2006/0130.
  • Alonso WJ, McCormick BJJ. EPIPOI: a user-friendly analytical tool for the extraction and visualization of temporal parameters from epidemiological time series. BMC Public Health. 2012;12:982. doi:10.1186/1471-2458-12-982.
  • Yu H, Alonso WJ, Feng L, Tan Y, Shu Y, Yang W, Viboud C. Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data. PLoS Med. 2013;10:e1001552. doi:10.1371/journal.pmed.1001552.
  • Chadha MS, Potdar VA, Saha S, Koul PA, Broor S, Dar L, Chawla-Sarkar M, Biswas D, Gunasekaran P, Abraham AM, et al. Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing. PLoS One. 2015;10:e0124122. doi:10.1371/journal.pone.0124122.
  • Saha S, Chadha M, Shu Y, Lijie W, Chittaganpitch M, Waicharoen S, KA L, Phengta V, Phonekeo D, Corwin A; ; . Divergent seasonal patterns of influenza types A and B across latitude gradient in Tropical Asia. Influenza Other Respir Viruses. 2016;10:176–84. doi:10.1111/irv.12372.
  • Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng Y-M, Gunalan V, Lin X, et al. The contrasting phylodynamics of human influenza B viruses. eLife. 2015;4:e05055. doi:10.7554/eLife.05055.
  • Beck HE, Zimmermann NE, McVicar TR, Vergopolan N, Berg A, Wood EF. Present and future Köppen-Geiger climate classification maps at 1-km resolution. Sci Data. 2018;5:180214.
  • Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, JM G, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet Lond Engl. 2018;391:1285–300.
  • Yang L, Ma S, Chen PY, He JF, Chan KP, Chow A, Ou CQ, Deng AP, Hedley AJ, Wong CM, et al. Influenza associated mortality in the subtropics and tropics: results from three Asian cities. Vaccine. 2011;29:8909–14. doi:10.1016/j.vaccine.2011.09.071.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019;4:e473–e481. doi:10.1016/S2468-2667(19)30163-X.
  • Minhaz Ud-Dean SM. Structural explanation for the effect of humidity on persistence of airborne virus: seasonality of influenza. J Theor Biol. 2010;264:822–29. doi:10.1016/j.jtbi.2010.03.013.
  • Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol. 2010;8. doi:10.1371/annotation/35686514-b7a9-4f65-9663-7baefc0d63c0.
  • Tamerius JD, Shaman J, WJ A, Bloom-Feshbach K, CK U, Comrie A, Viboud C. Environmental predictors of seasonal influenza epidemics across temperate and tropical climates. PLoS Pathog. 2013;9. doi:10.1371/annotation/df689228-603f-4a40-bfbf-a38b13f88147.
  • Deyle ER, Maher MC, Hernandez RD, Basu S, Sugihara G. Global environmental drivers of influenza. Proc Natl Acad Sci U S A. 2016;113:13081–86. doi:10.1073/pnas.1607747113.
  • Litvinova M, Liu Q-H, Kulikov ES, Ajelli M. Reactive school closure weakens the network of social interactions and reduces the spread of influenza. Proc Natl Acad Sci U S A. 2019;116:13174–81. doi:10.1073/pnas.1821298116.
  • Gautret P, Angelo KM, Asgeirsson H, Duvignaud A, van Genderen PJJ, Bottieau E, Chen LH, Parker S, Connor BA, Barnett ED, et al. International mass gatherings and travel-associated illness: A GeoSentinel cross-sectional, observational study. Travel Med Infect Dis. 2019;101504. doi:10.1016/j.tmaid.2019.101504.
  • Zhao X, Ning Y, Chen MI-C, Cook AR. Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country. Am J Epidemiol. 2018;187:135–43. doi:10.1093/aje/kwx201.
  • Wei VWI, Wong JYT, Perera RAPM, Kwok KO, Fang VJ, Barr IG, Peiris JSM, Riley S, Cowling BJ, et al. Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015. PLoS One. 2018;13:e0197504. doi:10.1371/journal.pone.0197504.
  • Wen F, Bedford T, Cobey S. Explaining the geographical origins of seasonal influenza A (H3N2). Proc R Soc B Biol Sci. 2016;283. doi:10.1098/rspb.2016.1312.
  • Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320:340–46. doi:10.1126/science.1154137.
  • Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523:217–20. doi:10.1038/nature14460.
  • Sheldenkar A, Lim F, Yung CF, Lwin MO. Acceptance and uptake of influenza vaccines in Asia: a systematic review. Vaccine. 2019;37:4896–905. doi:10.1016/j.vaccine.2019.07.011.
  • Zhao X, Fang VJ, Ohmit SE, Monto AS, Cook AR, Cowling BJ. Quantifying protection against influenza virus infection measured by hemagglutination-inhibition assays in vaccine trials. Epidemiol Camb Mass. 2016;27:143–51. doi:10.1097/EDE.0000000000000402.
  • Petrie JG, Ohmit SE, Johnson E, Truscon R, Monto AS. Persistence of antibodies to influenza hemagglutinin and neuraminidase following one or two years of influenza vaccination. J Infect Dis. 2015;212:1914–22. doi:10.1093/infdis/jiv313.
  • Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine. 2010;28:3929–35. doi:10.1016/j.vaccine.2010.03.067.
  • Hsu JP, Zhao X, Chen MIC, Cook AR, Lee V, Lim WY, Tan L, Barr IG, Jiang L, Tan CL, et al. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.. BMC Infect Dis. 2014;14. doi:10.1186/1471-2334-14-414
  • Young B, Zhao X, Cook AR, Parry CM, Wilder-Smith A, Cheng I. Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. Vaccine. 2017;35:212–21.
  • Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H, Gefenaite G, WT H, la Bastide-van Gemert S, Martinez-Baz I, et al. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017;5:200–11.
  • Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31:3104–09. doi:10.1016/j.vaccine.2013.04.026.
  • Feng S, Cowling BJ, Sullivan SG. Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings. Vaccine. 2016;34:1672–79. doi:10.1016/j.vaccine.2016.02.039.
  • Feng S, Cowling BJ, Kelly H, Sullivan SG. Estimating influenza vaccine effectiveness with the test-negative design using alternative control groups: a systematic review and meta-analysis. Am J Epidemiol. 2018;187:389–97. doi:10.1093/aje/kwx251.
  • Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ. Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am J Epidemiol. 2016;184:345–53. doi:10.1093/aje/kww064.
  • Ray GT, Lewis N, Klein NP, Daley MF, Wang SV, Kulldorff M, Fireman B. Intra-season Waning of Influenza Vaccine Effectiveness. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018. doi:10.1093/cid/ciy770.
  • Ng Y, Nandar K, Chua LAV, Mak TM, Foo K, Muhammad IR, Low CKK, Ma S, Ooi SPL, Lin RTP, et al. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore’s long term care facilities, 2017. Vaccine. 2019;37:3925–31. doi:10.1016/j.vaccine.2019.03.054.
  • Tam JS, Capeding MRZ, Lum LCS, Chotpitayasunondh T, Jiang Z, Huang L-M, Lee BW, Qian Y, Samakoses R, Lolekha S, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26:619–28. doi:10.1097/INF.0b013e31806166f8.
  • Petrie JG, Ohmit SE, Truscon R, Johnson E, TM B, MZ L, Eichelberger MC, AS M. Modest waning of influenza vaccine efficacy and antibody titers during the 2007-2008 influenza season. J Infect Dis. 2016;214:1142–49. doi:10.1093/infdis/jiw105.
  • Ferdinands JM, Alyanak E, Reed C, Fry AM. Waning of influenza vaccine protection: exploring the trade-offs of changes in vaccination timing among older adults. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019. doi:10.1093/cid/ciz452.
  • DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45. doi:10.1056/NEJMoa1315727.
  • Dunkle LM, Izikson R, Patriarca P, Goldenthal KL, Muse D, Callahan J, MM C. Efficacy of recombinant influenza vaccine in adults 50 years of age or older. N Engl J Med. 2017;376:2427–36. doi:10.1056/NEJMoa1608862.
  • Frey SE, Aplasca-De Los Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK. Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014;32:5027–34. doi:10.1016/j.vaccine.2014.07.013.
  • Kim DK, Riley LE, Hunter P. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older — United States, 2018. Morb Mortal Wkly Rep. 2018;67:158–60.
  • Ng TWY, Cowling BJ, Gao HZ, Thompson MG. Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis. J Infect Dis. 2019;219:1525–35. doi:10.1093/infdis/jiy720.
  • Chang L-J, et al. Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: a phase 3 randomized clinical trial. Vaccine. 2019;37:5825–34. doi:10.1016/j.vaccine.2019.08.016.
  • Feery BJ, Cheyne IM, Hampson AW, Atkinson MI. Antibody response to one and two doses of influenza virus subunit vaccine. Med J Aust. 1976;1:188–89.
  • Gross PA, Weksler ME, Quinnan GV, Douglas RG, Gaerlan PF, Denning CR. Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol. 1987;25:1763–65.
  • Keren G, Segev S, Morag A, Zakay‐Rones Z, Barzilai A, Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol. 1988;25:85–89. doi:10.1002/jmv.1890250112.
  • Mancini G, Arangio-Ruiz G, Bianchi B, Diana L, Macchia T, Donatelli I, MR C, Campitelli L, Ruggieri A. Influenza vaccination in elderly residents in nursing homes: immune response to trivalent and monovalent inactivated influenza virus vaccine in the season 1986-87. Eur J Epidemiol. 1989;5:214–18. doi:10.1007/BF00156833.
  • Fagiolo U, Amadori A, Cozzi E, Bendo R, Lama M, Douglas A, Palu G. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging Milan Italy. 1993;5:451–58.
  • Cools HJM, Gussekloo J, Remmerswaal JEM, Remarque EJ, Kroes ACM. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. J Med Virol. 2009;81:908–14. doi:10.1002/jmv.v81:5.
  • Liao Z, Xu X, Liang Y, Xiong Y, Chen R, Ni J. Effect of a booster dose of influenza vaccine in patients with hemodialysis, peritoneal dialysis and renal transplant recipients: A systematic literature review and meta-analysis. Hum Vaccines Immunother. 2016;12:2909–15. doi:10.1080/21645515.2016.1201623.
  • Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, JM M, Fortun J, Muñoz P, et al. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64:829–38. doi:10.1093/cid/ciw855.
  • Czako R, Subbarao K. Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virol. 2015;10:1033–47. doi:10.2217/fvl.15.69.
  • Young B, Sadarangani S, Haur SY, Yung CF, Barr I, Connolly J, Chen M, Wilder-Smith A. Semiannual versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator-controlled, randomized superiority trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;69:121–29. doi:10.1093/cid/ciy836.
  • Tam YH, Valkenburg SA, Perera RA, Wong JH, Fang VJ, Ng TW, Kwong AS, Tsui WW, Ip DK, Poon LL, et al. Immune responses to twice-annual influenza vaccination in older adults in Hong Kong. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;66:904–12. doi:10.1093/cid/cix900.
  • Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong - Full Text View - ClinicalTrials.gov. [accessed 2019 November 20]. https://clinicaltrials.gov/ct2/show/NCT02957890.